Home  >  Products  >  SEMA7A (semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group) ) Blocking Peptide (the C terminal of SEMA7A)(100ug)
SEMA7A (semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group) ) Blocking Peptide (the C terminal of SEMA7A)(100ug)

SEMA7A (semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group) ) Blocking Peptide (the C terminal of SEMA7A)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-SEMA7A Antibody (ARP64357_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP64357
Size: 100ug
Weight: 68kDa
Gene: 8482
Format: Lyophilized powder
Target: The protein encoded by this gene binds to cell surfaces through a glycosylphosphatidylinositol (GPI) linkage. The encoded glycoprotein is found on activated lymphocytes and erythrocytes. This protein may be involved in immunomodulatory and neuronal processes. Defects in this gene can result in loss of bone mineral density (BMD). Three transcript variants encoding different isoforms have been found for this gene.
Alternative names: CD108; CDw108; H-SEMA-K1; H-Sema-L; JMH; MGC126692; MGC126696; SEMAK1; SEMAL
See Full Product Listings >